Ropes & Gray Advises Harbin Pharmaceutical in a $300 Million Strategic Investment and China Joint Venture with GNC Holdings, Inc. In addition, GNC and Harbin Pharmaceutical…
Ropes & Gray Advises Harbin Pharmaceutical in a $300 Million Strategic Investment and China Joint Venture with GNC Holdings, Inc. In addition, GNC and Harbin Pharmaceutical…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.